Ann: Appendix 3B, page-7

As I have stated before, its a transparency issue as to why the SP performs as it does, the avoidance of information is the issue, none of the deals have been explained at all, just the action is understood instead of the reason behind the deal, its smacks of disregard, I would like to know so many things but we will never be privy to: HPX issue, nor African venture, ..What is going on with that, weren't they in Africa recently? No details, maybe its dust? Now we have a new tenement with which to focus, a new CR which today stated it was for Mars AT and FR.....Is $550k enough to do both? I very much doubt it, but maybe the JV partners are putting in an effort? We have NO idea, Just holding on to see if there is any positives in the coming drill round, I sure hope so given the valuation advances the research achieved for ENT. Paltry valuation $4.8m given the value of ENT prime asset.